Latest Pharma Insights
Dexcom Announced Launch Of One+ CGM In UK, State Of Type 2 Report
Dexcom launches its highly customizable One+ continuous glucose monitor in the UK as well as a state of type 2...
Medtech Insight - May 20, 2024
Dexcom launches its highly customizable One+ continuous glucose monitor in the UK as well as a state of type 2...
Medtech Insight - May 20, 2024
More Pediatric Cancer Trials Conducted Due To RACE Act
Initial data looks promising as the FDA’s pediatric oncology subcommittee is set to discuss how recent legislative changes have impacted...
Pink Sheet - May 20, 2024
Initial data looks promising as the FDA’s pediatric oncology subcommittee is set to discuss how recent legislative changes have impacted...
Pink Sheet - May 20, 2024
Amgen/AstraZeneca’s Tezspire Shows Efficacy In Broader COPD Population
Anti-TSLP antibody Tezspire (tezepelumab) showed efficacy in a Phase IIa study versus placebo in COPD patients with lower eosinophil levels...
Scrip - May 20, 2024
Anti-TSLP antibody Tezspire (tezepelumab) showed efficacy in a Phase IIa study versus placebo in COPD patients with lower eosinophil levels...
Scrip - May 20, 2024
Regulatory Overhaul Needed For Innovative Techs, Gottlieb Says
In a speech last week, former US FDA Commissioner Scott Gottlieb said establishing dynamic tools, including active registries and firm-based...
Medtech Insight - May 20, 2024
In a speech last week, former US FDA Commissioner Scott Gottlieb said establishing dynamic tools, including active registries and firm-based...
Medtech Insight - May 20, 2024
Dyne Hopes MD1 And DMD Mid-Stage Data Can Lead To Accelerated Approval
Phase I/II data for its ADC candidates in myotonic dystrophy type 1 and Duchenne muscular dystrophy indicate potential for biomarker-based...
Scrip - May 20, 2024
Phase I/II data for its ADC candidates in myotonic dystrophy type 1 and Duchenne muscular dystrophy indicate potential for biomarker-based...
Scrip - May 20, 2024
Endeavor Rockets Ahead With IPF Drug After Phase IIa Results
The biotech plans to run a Phase II study of ENV-101 in IPF and PPF, followed by a Phase III...
Scrip - May 20, 2024
The biotech plans to run a Phase II study of ENV-101 in IPF and PPF, followed by a Phase III...
Scrip - May 20, 2024
US FDA Looking To Modernize Clinical Trial Regulations To Spur ‘Evolution’ In Research
The Center for Drug Evaluation and Research’s new Center for Clinical Trial Innovation (C3TI) may lead a “targeted” effort to...
Pink Sheet - May 20, 2024
The Center for Drug Evaluation and Research’s new Center for Clinical Trial Innovation (C3TI) may lead a “targeted” effort to...
Pink Sheet - May 20, 2024
‘Antiquated’ Regulations Slowing Adoption of Innovative Clinical Trial Approaches
The current regulations were written when clinical trials involved far fewer entities, and a certain amount of ‘contortion’ is necessary...
Pink Sheet - May 20, 2024
The current regulations were written when clinical trials involved far fewer entities, and a certain amount of ‘contortion’ is necessary...
Pink Sheet - May 20, 2024
The Looming US Election Weighs On The Minds Of Pharma
The US presidential election in November could mean IRA expansion from a Biden win, but a Trump victory also brings...
Scrip - May 20, 2024
The US presidential election in November could mean IRA expansion from a Biden win, but a Trump victory also brings...
Scrip - May 20, 2024
Pair Of Deaths Linked To Latest Recall Of Abbott HeartMate Pump
Abbott has issued a recall of several hundred HeartMate 3 pumps used to support patients with heart failure after reports...
Medtech Insight - May 20, 2024
Abbott has issued a recall of several hundred HeartMate 3 pumps used to support patients with heart failure after reports...
Medtech Insight - May 20, 2024
UK Generic Price Spikes Ease In April
With UK shortages and price rises making headlines in early 2024, April’s generic pricing data suggested an easing of pricing...
Generics Bulletin - May 20, 2024
With UK shortages and price rises making headlines in early 2024, April’s generic pricing data suggested an easing of pricing...
Generics Bulletin - May 20, 2024
Over The Counter: How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane
Focus and persistence are the keys to successful brand and company growth, according to TheOTCLab's founder and CEO Albert Swane...
HBW Insight - May 20, 2024
Focus and persistence are the keys to successful brand and company growth, according to TheOTCLab's founder and CEO Albert Swane...
HBW Insight - May 20, 2024
Stock Watch: Paradoxical Q1 Earnings Reactions
Falling sales are not typically welcomed by investors, while good revenue growth is prized. The first-quarter earnings season provided exceptions...
Scrip - May 20, 2024
Falling sales are not typically welcomed by investors, while good revenue growth is prized. The first-quarter earnings season provided exceptions...
Scrip - May 20, 2024
EU To Suspend 17-OHPC Preterm Birth Drugs A Year After US Pulled Makena
17-OHPC medicines are to be pulled from the market in Europe due to a potential link with cancer and the...
Pink Sheet - May 20, 2024
17-OHPC medicines are to be pulled from the market in Europe due to a potential link with cancer and the...
Pink Sheet - May 20, 2024
Bayer’s Menopause Drug Has An Edge But Still Much To Prove
Phase III results suggest Bayer’s elinzanetant has a safety and efficacy advantage over its Astellas rival in reducing hot flashes...
Scrip - May 20, 2024
Phase III results suggest Bayer’s elinzanetant has a safety and efficacy advantage over its Astellas rival in reducing hot flashes...
Scrip - May 20, 2024
Deals in Depth: April 2024
Seven $1bn+ alliances were penned in April. In the top alliance by deal value, Medincell entered a collaboration with AbbVie...
In Vivo - May 20, 2024
Seven $1bn+ alliances were penned in April. In the top alliance by deal value, Medincell entered a collaboration with AbbVie...
In Vivo - May 20, 2024
Novavax Sanofi Pact Pacifies Unhappy Investor For Now
The US vaccines maker has been under the cosh from a very vocal investor who was unhappy with the performance...
Scrip - May 20, 2024
The US vaccines maker has been under the cosh from a very vocal investor who was unhappy with the performance...
Scrip - May 20, 2024
End In Sight For Onerous EU Signal Detection Pilot
A keenly-awaited legislative amendment that is expected to be adopted by the end of this year would introduce more proportionate...
Pink Sheet - May 20, 2024
A keenly-awaited legislative amendment that is expected to be adopted by the end of this year would introduce more proportionate...
Pink Sheet - May 20, 2024
EMA Updates Trials Portal With New Fields On Sharing Participant Data
Sponsors can now disclose their intention of sharing deidentified individual participant data when they register a study in the EU...
Pink Sheet - May 20, 2024
Sponsors can now disclose their intention of sharing deidentified individual participant data when they register a study in the EU...
Pink Sheet - May 20, 2024
Taking European Biosimilars To The Next Level
Europe’s biosimilars market now has many years of progress under its belt. But how can this successful foundation be built...
Generics Bulletin - May 20, 2024
Europe’s biosimilars market now has many years of progress under its belt. But how can this successful foundation be built...
Generics Bulletin - May 20, 2024
'Future Fit' Cipla: Play In Oligonucleotides, Obesity Amid Promoter Stake Action
Cipla is stepping into the oligonucleotides space, where it also hopes to help shape the regulatory environment. Action is also...
Generics Bulletin - May 20, 2024
Cipla is stepping into the oligonucleotides space, where it also hopes to help shape the regulatory environment. Action is also...
Generics Bulletin - May 20, 2024
Entering Estonia: To Build Bigger Castles, You Need A Better Sandbox
Estonia is hoping to create a brighter future by attracting leading startups to its borders, a process that will bring...
In Vivo - May 20, 2024
Estonia is hoping to create a brighter future by attracting leading startups to its borders, a process that will bring...
In Vivo - May 20, 2024
Will Actinium Be Big Pharma’s Next Radiopharmaceuticals Acquisition?
With big pharma on a radiopharmaceuticals buying spree, New York-based Actinium Pharmaceuticals has been pointed to as the next potential...
In Vivo - May 20, 2024
With big pharma on a radiopharmaceuticals buying spree, New York-based Actinium Pharmaceuticals has been pointed to as the next potential...
In Vivo - May 20, 2024
Amgen/AstraZeneca’s Tezspire Shows Efficacy In Broader COPD Population
Anti-TSLP antibody Tezspire (tezepelumab) showed efficacy in a Phase IIa study versus placebo in COPD patients with lower eosinophil levels...
Scrip - May 20, 2024
Anti-TSLP antibody Tezspire (tezepelumab) showed efficacy in a Phase IIa study versus placebo in COPD patients with lower eosinophil levels...
Scrip - May 20, 2024
Dyne Hopes MD1 And DMD Mid-Stage Data Can Lead To Accelerated Approval
Phase I/II data for its ADC candidates in myotonic dystrophy type 1 and Duchenne muscular dystrophy indicate potential for biomarker-based...
Scrip - May 20, 2024
Phase I/II data for its ADC candidates in myotonic dystrophy type 1 and Duchenne muscular dystrophy indicate potential for biomarker-based...
Scrip - May 20, 2024
Endeavor Rockets Ahead With IPF Drug After Phase IIa Results
The biotech plans to run a Phase II study of ENV-101 in IPF and PPF, followed by a Phase III...
Scrip - May 20, 2024
The biotech plans to run a Phase II study of ENV-101 in IPF and PPF, followed by a Phase III...
Scrip - May 20, 2024
The Looming US Election Weighs On The Minds Of Pharma
The US presidential election in November could mean IRA expansion from a Biden win, but a Trump victory also brings...
Scrip - May 20, 2024
The US presidential election in November could mean IRA expansion from a Biden win, but a Trump victory also brings...
Scrip - May 20, 2024
Stock Watch: Paradoxical Q1 Earnings Reactions
Falling sales are not typically welcomed by investors, while good revenue growth is prized. The first-quarter earnings season provided exceptions...
Scrip - May 20, 2024
Falling sales are not typically welcomed by investors, while good revenue growth is prized. The first-quarter earnings season provided exceptions...
Scrip - May 20, 2024
Bayer’s Menopause Drug Has An Edge But Still Much To Prove
Phase III results suggest Bayer’s elinzanetant has a safety and efficacy advantage over its Astellas rival in reducing hot flashes...
Scrip - May 20, 2024
Phase III results suggest Bayer’s elinzanetant has a safety and efficacy advantage over its Astellas rival in reducing hot flashes...
Scrip - May 20, 2024
Novavax Sanofi Pact Pacifies Unhappy Investor For Now
The US vaccines maker has been under the cosh from a very vocal investor who was unhappy with the performance...
Scrip - May 20, 2024
The US vaccines maker has been under the cosh from a very vocal investor who was unhappy with the performance...
Scrip - May 20, 2024
More Pediatric Cancer Trials Conducted Due To RACE Act
Initial data looks promising as the FDA’s pediatric oncology subcommittee is set to discuss how recent legislative changes have impacted...
Pink Sheet - May 20, 2024
Initial data looks promising as the FDA’s pediatric oncology subcommittee is set to discuss how recent legislative changes have impacted...
Pink Sheet - May 20, 2024
US FDA Looking To Modernize Clinical Trial Regulations To Spur ‘Evolution’ In Research
The Center for Drug Evaluation and Research’s new Center for Clinical Trial Innovation (C3TI) may lead a “targeted” effort to...
Pink Sheet - May 20, 2024
The Center for Drug Evaluation and Research’s new Center for Clinical Trial Innovation (C3TI) may lead a “targeted” effort to...
Pink Sheet - May 20, 2024
‘Antiquated’ Regulations Slowing Adoption of Innovative Clinical Trial Approaches
The current regulations were written when clinical trials involved far fewer entities, and a certain amount of ‘contortion’ is necessary...
Pink Sheet - May 20, 2024
The current regulations were written when clinical trials involved far fewer entities, and a certain amount of ‘contortion’ is necessary...
Pink Sheet - May 20, 2024
EU To Suspend 17-OHPC Preterm Birth Drugs A Year After US Pulled Makena
17-OHPC medicines are to be pulled from the market in Europe due to a potential link with cancer and the...
Pink Sheet - May 20, 2024
17-OHPC medicines are to be pulled from the market in Europe due to a potential link with cancer and the...
Pink Sheet - May 20, 2024
End In Sight For Onerous EU Signal Detection Pilot
A keenly-awaited legislative amendment that is expected to be adopted by the end of this year would introduce more proportionate...
Pink Sheet - May 20, 2024
A keenly-awaited legislative amendment that is expected to be adopted by the end of this year would introduce more proportionate...
Pink Sheet - May 20, 2024
EMA Updates Trials Portal With New Fields On Sharing Participant Data
Sponsors can now disclose their intention of sharing deidentified individual participant data when they register a study in the EU...
Pink Sheet - May 20, 2024
Sponsors can now disclose their intention of sharing deidentified individual participant data when they register a study in the EU...
Pink Sheet - May 20, 2024
Dexcom Announced Launch Of One+ CGM In UK, State Of Type 2 Report
Dexcom launches its highly customizable One+ continuous glucose monitor in the UK as well as a state of type 2...
Medtech Insight - May 20, 2024
Dexcom launches its highly customizable One+ continuous glucose monitor in the UK as well as a state of type 2...
Medtech Insight - May 20, 2024
Regulatory Overhaul Needed For Innovative Techs, Gottlieb Says
In a speech last week, former US FDA Commissioner Scott Gottlieb said establishing dynamic tools, including active registries and firm-based...
Medtech Insight - May 20, 2024
In a speech last week, former US FDA Commissioner Scott Gottlieb said establishing dynamic tools, including active registries and firm-based...
Medtech Insight - May 20, 2024
Pair Of Deaths Linked To Latest Recall Of Abbott HeartMate Pump
Abbott has issued a recall of several hundred HeartMate 3 pumps used to support patients with heart failure after reports...
Medtech Insight - May 20, 2024
Abbott has issued a recall of several hundred HeartMate 3 pumps used to support patients with heart failure after reports...
Medtech Insight - May 20, 2024
Over The Counter: How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane
Focus and persistence are the keys to successful brand and company growth, according to TheOTCLab's founder and CEO Albert Swane...
HBW Insight - May 20, 2024
Focus and persistence are the keys to successful brand and company growth, according to TheOTCLab's founder and CEO Albert Swane...
HBW Insight - May 20, 2024
UK Generic Price Spikes Ease In April
With UK shortages and price rises making headlines in early 2024, April’s generic pricing data suggested an easing of pricing...
Generics Bulletin - May 20, 2024
With UK shortages and price rises making headlines in early 2024, April’s generic pricing data suggested an easing of pricing...
Generics Bulletin - May 20, 2024
Taking European Biosimilars To The Next Level
Europe’s biosimilars market now has many years of progress under its belt. But how can this successful foundation be built...
Generics Bulletin - May 20, 2024
Europe’s biosimilars market now has many years of progress under its belt. But how can this successful foundation be built...
Generics Bulletin - May 20, 2024
'Future Fit' Cipla: Play In Oligonucleotides, Obesity Amid Promoter Stake Action
Cipla is stepping into the oligonucleotides space, where it also hopes to help shape the regulatory environment. Action is also...
Generics Bulletin - May 20, 2024
Cipla is stepping into the oligonucleotides space, where it also hopes to help shape the regulatory environment. Action is also...
Generics Bulletin - May 20, 2024
Deals in Depth: April 2024
Seven $1bn+ alliances were penned in April. In the top alliance by deal value, Medincell entered a collaboration with AbbVie...
In Vivo - May 20, 2024
Seven $1bn+ alliances were penned in April. In the top alliance by deal value, Medincell entered a collaboration with AbbVie...
In Vivo - May 20, 2024
Entering Estonia: To Build Bigger Castles, You Need A Better Sandbox
Estonia is hoping to create a brighter future by attracting leading startups to its borders, a process that will bring...
In Vivo - May 20, 2024
Estonia is hoping to create a brighter future by attracting leading startups to its borders, a process that will bring...
In Vivo - May 20, 2024
Will Actinium Be Big Pharma’s Next Radiopharmaceuticals Acquisition?
With big pharma on a radiopharmaceuticals buying spree, New York-based Actinium Pharmaceuticals has been pointed to as the next potential...
In Vivo - May 20, 2024
With big pharma on a radiopharmaceuticals buying spree, New York-based Actinium Pharmaceuticals has been pointed to as the next potential...
In Vivo - May 20, 2024